October 30, 2024
Docket Number: FDA-2023-D-0093 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research This guideline is intended to provide recommendations on conducting bioequivalence (BE) studies […]
October 30, 2024
ORLANDO, Fla. — The rationale for using obesity medications in pediatric patients is that it’s using “a biological intervention to treat a biologically based disease,” according […]
October 30, 2024
In daily practice, physicians need a quick and simple way to assess whether a patient’s weight presents a health risk. For decades, the body mass index […]
October 30, 2024
Nearly 4 years since the first messenger RNA (mRNA) COVID-19 vaccines were developed, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is evolving more quickly […]
October 30, 2024
TOPLINE: Having a diagnosis of dementia is associated with an increase in emergency department (ED) visits in the United States, highlighting a potential health crisis and […]
October 29, 2024
Share on PinterestFrom frozen waffles and quarter pounders to Costco salmon and freeze-dried meat, there have been a number of food recalls in recent weeks due […]
October 29, 2024
On October 29, 2024, the Food and Drug Administration granted accelerated approval to asciminib (Scemblix, Novartis AG) for adult patients with newly diagnosed Philadelphia chromosome-positive chronic […]
October 29, 2024
Last April, the US Preventive Services Task Force (USPSTF) revised their breast cancer screening guidelines to recommend average-risk women start their screening mammograms at age 40, […]
October 29, 2024
After Funda Bachini, MD, a psychiatrist in Phoenix, Arizona, gave birth to her third child in 2017, she found herself irritable, struggling to sleep, and up […]